euCanSHare, EUCAN-Connect, and RECODID all centre on building cross-border data sharing infrastructure with FAIR principles and privacy safeguards.
THE RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE
Canadian academic health research institute specializing in transatlantic health data sharing, federated cohort platforms, and cross-border data governance.
Their core work
RI-MUHC is the research arm of McGill University Health Centre in Montreal, one of Canada's leading academic health science centres. In H2020, they specialize in large-scale health data infrastructure — building federated platforms for sharing cardiovascular, cohort, and infectious disease data across borders. They bring North American clinical cohort data and expertise in data governance, privacy, and harmonization to European research consortia, serving as a critical transatlantic bridge for multi-country health studies.
What they specialise in
euCanSHare specifically builds an EU-Canada joint infrastructure for multi-study cardiovascular research with omics and imaging data.
EUCAN-Connect and RECODID focus on harmonizing high-dimensional cohort data across repositories, addressing metadata standards, ethics, and ownership.
MINDMAP studied determinants and policies for mental wellbeing in ageing urban populations — their only funded project (EUR 367K).
METAFRAX (2021, MSCA-IF) explores unconventional NMDA receptor signalling in Fragile X Syndrome — a departure from their data infrastructure focus.
How they've shifted over time
Their early H2020 work (2016–2018) centred on building centralized cardiovascular data platforms with cloud infrastructure, blockchain for legal interoperability, and FAIR data principles — essentially pioneering EU-Canada health data bridges. From 2019 onward, the focus broadened to federated cohort analysis across disease areas (infectious disease, population health), with greater emphasis on data harmonization, privacy, and governance rather than platform construction. The 2021 METAFRAX project signals a secondary line in fundamental neuroscience that diverges from their data infrastructure core.
Moving from building specific disease-area data platforms toward becoming a generalist partner for cross-border health data governance and federated analysis, with a minor thread in neuroscience emerging.
How they like to work
RI-MUHC operates exclusively as a participant or third party — they have never coordinated an H2020 project, which is typical for non-EU partners joining European consortia. They consistently join large consortia (56 unique partners across 5 projects), contributing Canadian clinical data assets and transatlantic perspective rather than leading project management. Their repeat presence in data-sharing consortia suggests they are a trusted, go-to Canadian partner when European projects need North American cohort linkage.
With 56 unique consortium partners across 18 countries, RI-MUHC has a broad European network despite being a Canadian institution. Their collaborations span major EU health research hubs, positioning them as the primary Canada-EU connector in health data infrastructure.
What sets them apart
As a Canadian institution embedded in European health data consortia, RI-MUHC offers something few EU partners can: direct access to North American clinical cohorts and a transatlantic bridge for data sharing. Their deep expertise in data governance, privacy, and FAIR compliance — developed across multiple large-scale projects — makes them particularly valuable when projects need to navigate cross-jurisdictional data regulations. For consortium builders, they are the partner who makes "EU-Canada" in a project title credible.
Highlights from their portfolio
- euCanSHareFlagship EU-Canada cardiovascular data infrastructure project combining omics, imaging, and cloud platforms — the project that defines RI-MUHC's transatlantic data bridge role.
- RECODIDExtended their data harmonization expertise into infectious disease cohorts, demonstrating versatility beyond cardiovascular research.
- METAFRAXAn MSCA Individual Fellowship on Fragile X Syndrome neuroscience — a surprising departure that signals emerging capability in fundamental brain research.